SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000156
Filing Date
2021-11-12
Accepted
2021-11-12 15:28:49
Documents
51
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210930x10q.htm   iXBRL 10-Q 791061
2 EXHIBIT 31.1 tmb-20210930xex31d1.htm EX-31.1 14256
3 EXHIBIT 31.2 tmb-20210930xex31d2.htm EX-31.2 13662
4 EXHIBIT 32.1 tmb-20210930xex32d1.htm EX-32.1 6661
5 EXHIBIT 32.2 tmb-20210930xex32d2.htm EX-32.2 6668
  Complete submission text file 0001410578-21-000156.txt   4178265

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210930.xsd EX-101.SCH 42674
7 EX-101.CAL tmb-20210930_cal.xml EX-101.CAL 25497
8 EX-101.DEF tmb-20210930_def.xml EX-101.DEF 188170
9 EX-101.LAB tmb-20210930_lab.xml EX-101.LAB 319300
10 EX-101.PRE tmb-20210930_pre.xml EX-101.PRE 267386
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210930x10q_htm.xml XML 571528
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40119 | Film No.: 211402949
SIC: 6770 Blank Checks